English press releases

Civil Society Organizations and Over 100 Governments Push for Reforms against Authoritarianism, Corruption, and Closing Civic Space

Open Government Partnership Global Summit to Showcase Reformers Who Are Implementing Commitments Made at White House Summit for Democracy WASHINGTON–(BUSINESS WIRE)– Days after the White...

Vifor Pharma comments on media speculation

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR ST. GALLEN, Switzerland–(BUSINESS WIRE)– Vifor is in discussions with CSL about a possible transaction. No...

BearingPoint study: The CEO as the Chief Environmental Officer is key for sustainable procurement

BearingPoint global study shows that having the CEO on your side to set the baseline measurement of carbon emissions is a must to achieve sustainable...

First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease

Vamifeport (VIT-2763) is the first oral ferroportin inhibitor investigated for treatment of diseases with ineffective production of red blood cells and iron overload such as...

SIGNA Sports United Expects to Close Business Combination with Yucaipa Acquisition Corporation on December 14, 2021

SIGNA Sports United and Yucaipa Acquisition Corporation expect to complete their business combination, subject to YAC shareholder approval Extraordinary general meeting of Yucaipa Acquisition Corporation...

Elliott Advisors Publishes Letter on Taylor Wimpey

LONDON–(BUSINESS WIRE)– Elliott Advisors (UK) Limited sent the following letter to the Board of Taylor Wimpey plc today. This press release features multimedia. View the...

Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors

LAUSANNE, Switzerland–(BUSINESS WIRE)– Philip Morris International Inc. (PMI) (NYSE: PM) today announced that on December 6, 2021, its Board of Directors appointed a new member,...

Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices

PMI publishes report detailing history, strategy, challenges, and progress made; ALP’s learnings will support the development of Verité’s upcoming ‘Farm Labor Due Diligence Toolkit’ LAUSANNE,...

Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee

  Hervé Gisserot will join Vifor Pharma as Chief Commercial Officer on 17 January 2022 Responsibilities of Sales, Marketing and Market Access to be streamlined...

Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury

  ST. GALLEN, Switzerland & UNIONDALE, N.Y.–(BUSINESS WIRE)– Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/ AD HOC ANNOUNCEMENT PURSUANT...

Sigfox Signs A Global Partnership With Skyhook To Improve Delivery of Geolocation Services

This new strategic partnership will contribute to Sigfox’s efforts to tailor cost efficient and performant services adapted for the massive IoT, and open a whole...

UK government awards Future RAN Competition funding to ADVA-led consortium

News summary: 5G DU-Volution project will develop open RAN solutions and boost country’s 5G supply chain ADVA building dedicated open RAN systems integration center in...

ADVA boosts PNT resilience with new software release

News summary: Today’s timing networks require PTP grandmaster clocks with robust, survivable PNT cybersecurity and protection against GNSS vulnerabilities Upgraded range of synchronization solutions now...

 KPMG Reports Global Revenues of $32.13 Billion for Fy21, Focus on Strategy Enables 10% Growth

LONDON–(BUSINESS WIRE)– KPMG International announced today annual aggregated revenues for KPMG firms globally of $32.13 billion for the fiscal year ending 30 September 2021 (FY21)....

Seagen Announces Updated Results from Pivotal HER2CLIMB Trial Evaluating TUKYSA® (tucatinib) in Patients with HER2-Positive Breast Cancer with Brain Metastases

– Exploratory Analyses from the Pivotal HER2CLIMB Trial Show Patients with Stable and Active Brain Metastases Treated with a TUKYSA Regimen Maintained a Survival Benefit...